Annual CFI
-$2400.00
-$40.60 K-106.28%
December 31, 2023
Summary
- As of February 8, 2025, CYTH annual cash flow from investing activities is -$2400.00, with the most recent change of -$40.60 thousand (-106.28%) on December 31, 2023.
- During the last 3 years, CYTH annual CFI has risen by +$11.60 thousand (+82.86%).
- CYTH annual CFI is now -100.25% below its all-time high of $942.90 thousand, reached on December 31, 2016.
Performance
CYTH Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
N/A
September 30, 2024
Summary
- CYTH quarterly cash flow from investing activities is not available.
Performance
CYTH Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFI
N/A
September 30, 2024
Summary
- CYTH TTM cash flow from investing activities is not available.
Performance
CYTH TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
CYTH Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -106.3% | - | - |
| 3 y3 years | +82.9% | - | - |
| 5 y5 years | -107.3% | - | - |
CYTH Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -106.3% | at low | ||||
| 5 y | 5-year | -106.3% | +82.9% | ||||
| alltime | all time | -100.3% | +99.6% |
Cyclo Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$2400.00(-106.3%) | - | - |
| Dec 2022 | $38.20 K(+158.1%) | $0.00(-100.0%) | $38.20 K(-21.2%) |
| Sep 2022 | - | $18.30 K(+72.6%) | $48.50 K(+31.1%) |
| Jun 2022 | - | $10.60 K(+14.0%) | $37.00 K(+78.7%) |
| Mar 2022 | - | $9300.00(-9.7%) | $20.70 K(+40.8%) |
| Dec 2021 | $14.80 K(-205.7%) | $10.30 K(+51.5%) | $14.70 K(-16.5%) |
| Sep 2021 | - | $6800.00(-219.3%) | $17.60 K(+1.7%) |
| Jun 2021 | - | -$5700.00(-272.7%) | $17.30 K(-42.7%) |
| Mar 2021 | - | $3300.00(-75.0%) | $30.20 K(-314.2%) |
| Dec 2020 | -$14.00 K(-138.8%) | $13.20 K(+103.1%) | -$14.10 K(-20.8%) |
| Sep 2020 | - | $6500.00(-9.7%) | -$17.80 K(+19.5%) |
| Jun 2020 | - | $7200.00(-117.6%) | -$14.90 K(+16.4%) |
| Mar 2020 | - | -$41.00 K(-531.6%) | -$12.80 K(-135.5%) |
| Dec 2019 | $36.10 K(+9.7%) | $9500.00(+1.1%) | $36.10 K(+4.9%) |
| Sep 2019 | - | $9400.00(+1.1%) | $34.40 K(+1.2%) |
| Jun 2019 | - | $9300.00(+17.7%) | $34.00 K(-13.9%) |
| Mar 2019 | - | $7900.00(+1.3%) | $39.50 K(+20.1%) |
| Dec 2018 | $32.90 K(+2.2%) | $7800.00(-13.3%) | $32.90 K(-4.6%) |
| Sep 2018 | - | $9000.00(-39.2%) | $34.50 K(+11.7%) |
| Jun 2018 | - | $14.80 K(+1038.5%) | $30.90 K(+40.5%) |
| Mar 2018 | - | $1300.00(-86.2%) | $22.00 K(-31.7%) |
| Dec 2017 | $32.20 K(-96.6%) | $9400.00(+74.1%) | $32.20 K(-96.6%) |
| Sep 2017 | - | $5400.00(-8.5%) | $950.40 K(-0.3%) |
| Jun 2017 | - | $5900.00(-48.7%) | $953.30 K(-0.2%) |
| Mar 2017 | - | $11.50 K(-98.8%) | $955.60 K(+1.3%) |
| Dec 2016 | $942.90 K(-325.3%) | $927.60 K(>+9900.0%) | $943.00 K(-1528.8%) |
| Sep 2016 | - | $8300.00(+1.2%) | -$66.00 K(-64.7%) |
| Jun 2016 | - | $8200.00(-845.5%) | -$187.00 K(-28.2%) |
| Mar 2016 | - | -$1100.00(-98.6%) | -$260.50 K(-37.8%) |
| Dec 2015 | -$418.50 K(+140.7%) | -$81.40 K(-27.8%) | -$418.50 K(+11.5%) |
| Sep 2015 | - | -$112.70 K(+72.6%) | -$375.50 K(+26.8%) |
| Jun 2015 | - | -$65.30 K(-59.0%) | -$296.20 K(+7.8%) |
| Mar 2015 | - | -$159.10 K(+314.3%) | -$274.70 K(+58.0%) |
| Dec 2014 | -$173.90 K(+12.3%) | -$38.40 K(+15.0%) | -$173.90 K(-22.7%) |
| Sep 2014 | - | -$33.40 K(-23.7%) | -$225.10 K(-12.0%) |
| Jun 2014 | - | -$43.80 K(-24.9%) | -$255.90 K(+20.5%) |
| Mar 2014 | - | -$58.30 K(-34.9%) | -$212.40 K(+37.1%) |
| Dec 2013 | -$154.90 K(-6.8%) | -$89.60 K(+39.6%) | -$154.90 K(+9.6%) |
| Sep 2013 | - | -$64.20 K(>+9900.0%) | -$141.30 K(+21.1%) |
| Jun 2013 | - | -$300.00(-62.5%) | -$116.70 K(-2.6%) |
| Mar 2013 | - | -$800.00(-98.9%) | -$119.80 K(-27.9%) |
| Dec 2012 | -$166.20 K(-70.0%) | -$76.00 K(+91.9%) | -$166.20 K(+83.8%) |
| Sep 2012 | - | -$39.60 K(+1064.7%) | -$90.40 K(-67.8%) |
| Jun 2012 | - | -$3400.00(-92.8%) | -$280.70 K(-46.4%) |
| Mar 2012 | - | -$47.20 K(>+9900.0%) | -$523.90 K(-5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | -$553.80 K(+23.3%) | -$200.00(-99.9%) | -$553.80 K(-12.5%) |
| Sep 2011 | - | -$229.90 K(-6.8%) | -$632.80 K(+34.2%) |
| Jun 2011 | - | -$246.60 K(+219.8%) | -$471.40 K(+7.3%) |
| Mar 2011 | - | -$77.10 K(-2.7%) | -$439.20 K(-2.2%) |
| Dec 2010 | -$449.20 K(+1124.0%) | -$79.20 K(+15.6%) | -$449.20 K(+24.8%) |
| Sep 2010 | - | -$68.50 K(-68.1%) | -$360.00 K(+22.2%) |
| Jun 2010 | - | -$214.40 K(+146.2%) | -$294.50 K(+189.9%) |
| Mar 2010 | - | -$87.10 K(-971.0%) | -$101.60 K(+176.8%) |
| Dec 2009 | -$36.70 K(-122.5%) | $10.00 K(-433.3%) | -$36.70 K(-49.0%) |
| Sep 2009 | - | -$3000.00(-86.0%) | -$72.00 K(-11.5%) |
| Jun 2009 | - | -$21.50 K(-3.2%) | -$81.40 K(+181.7%) |
| Mar 2009 | - | -$22.20 K(-12.3%) | -$28.90 K(-117.7%) |
| Dec 2008 | $163.40 K(-176.5%) | -$25.30 K(+104.0%) | $163.40 K(-22.2%) |
| Sep 2008 | - | -$12.40 K(-140.0%) | $210.10 K(+66.2%) |
| Jun 2008 | - | $31.00 K(-81.8%) | $126.40 K(-519.9%) |
| Mar 2008 | - | $170.10 K(+694.9%) | -$30.10 K(-85.9%) |
| Dec 2007 | -$213.60 K(+3041.2%) | $21.40 K(-122.3%) | -$213.60 K(-5.7%) |
| Sep 2007 | - | -$96.10 K(-23.4%) | -$226.50 K(+6.7%) |
| Jun 2007 | - | -$125.50 K(+836.6%) | -$212.20 K(+1170.7%) |
| Mar 2007 | - | -$13.40 K(-257.6%) | -$16.70 K(+145.6%) |
| Dec 2006 | -$6800.00(-95.1%) | $8500.00(-110.4%) | -$6800.00(-85.5%) |
| Sep 2006 | - | -$81.80 K(-216.9%) | -$46.80 K(-231.8%) |
| Jun 2006 | - | $70.00 K(-2100.0%) | $35.50 K(-128.2%) |
| Mar 2006 | - | -$3500.00(-88.9%) | -$126.00 K(-8.7%) |
| Dec 2005 | -$138.00 K(+64.5%) | -$31.50 K(-6400.0%) | -$138.00 K(+42.7%) |
| Sep 2005 | - | $500.00(-100.5%) | -$96.70 K(-38.5%) |
| Jun 2005 | - | -$91.50 K(+490.3%) | -$157.20 K(+106.3%) |
| Mar 2005 | - | -$15.50 K(-258.2%) | -$76.20 K(-9.2%) |
| Dec 2004 | -$83.90 K(+27.3%) | $9800.00(-116.3%) | -$83.90 K(-19.9%) |
| Sep 2004 | - | -$60.00 K(+471.4%) | -$104.70 K(+30.7%) |
| Jun 2004 | - | -$10.50 K(-54.7%) | -$80.10 K(-1.0%) |
| Mar 2004 | - | -$23.20 K(+110.9%) | -$80.90 K(+22.6%) |
| Dec 2003 | -$65.90 K(+285.4%) | -$11.00 K(-68.9%) | -$66.00 K(+16.2%) |
| Sep 2003 | - | -$35.40 K(+213.3%) | -$56.80 K(+165.4%) |
| Jun 2003 | - | -$11.30 K(+36.1%) | -$21.40 K(-39.5%) |
| Mar 2003 | - | -$8300.00(+361.1%) | -$35.40 K(+107.0%) |
| Dec 2002 | -$17.10 K(-4375.0%) | -$1800.00(<-9900.0%) | -$17.10 K(-8.6%) |
| Sep 2002 | - | $0.00(-100.0%) | -$18.70 K(+7.5%) |
| Jun 2002 | - | -$25.30 K(-353.0%) | -$17.40 K(-320.3%) |
| Mar 2002 | - | $10.00 K(-394.1%) | $7900.00(+1875.0%) |
| Dec 2001 | $400.00(-100.5%) | -$3400.00(-361.5%) | $400.00(-89.5%) |
| Sep 2001 | - | $1300.00(>+9900.0%) | $3800.00(+52.0%) |
| Jun 2001 | - | $0.00(-100.0%) | $2500.00(0.0%) |
| Mar 2001 | - | $2500.00 | $2500.00 |
| Dec 2000 | -$78.70 K | - | - |
FAQ
- What is Cyclo Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Cyclo Therapeutics?
- What is Cyclo Therapeutics annual CFI year-on-year change?
- What is the all time high quarterly CFI for Cyclo Therapeutics?
- What is the all time high TTM CFI for Cyclo Therapeutics?
What is Cyclo Therapeutics annual cash flow from investing activities?
The current annual CFI of CYTH is -$2400.00
What is the all time high annual CFI for Cyclo Therapeutics?
Cyclo Therapeutics all-time high annual cash flow from investing activities is $942.90 K
What is Cyclo Therapeutics annual CFI year-on-year change?
Over the past year, CYTH annual cash flow from investing activities has changed by -$40.60 K (-106.28%)
What is the all time high quarterly CFI for Cyclo Therapeutics?
Cyclo Therapeutics all-time high quarterly cash flow from investing activities is $927.60 K
What is the all time high TTM CFI for Cyclo Therapeutics?
Cyclo Therapeutics all-time high TTM cash flow from investing activities is $955.60 K